Literature DB >> 26070585

Patient Education and Adherence to Aerosol Therapy.

Arzu Ari1.   

Abstract

Nonadherence to prescribed medications results in disease instability and poor clinical control, with increases in hospital admissions, emergency room visits, school/work absenteeism, morbidity, and mortality. Poor patient adherence to therapy can be due to lack of cognition, competence, or contrivance. Patients who have not been trained or fail to understand use of drug and device combinations (cognition) often do not have the ability to use an aerosol device correctly (competence). Many patients have the competence to use the device correctly and know why they should use the device in the way they were taught; however, they still contrive to use it in an ineffective and suboptimal manner that reduces its efficiency and effectiveness. Ensuring effective aerosol therapy and optimizing its role in disease management involve not only delivery of aerosolized medications to the lungs, but also understanding why, when, and how to use the medications, competence to use the device, motivation to adhere to therapy, and not contriving to use the device in a way that will prevent effective drug delivery. This paper explains some of the problems with patient education and adherence to aerosol therapy and suggests strategies to evaluate, monitor, and improve patient adherence effectively in primary care. Factors affecting patient adherence to prescribed medications, effective educational interventions, and strategies to promote patient adherence to aerosol therapy are also discussed.
Copyright © 2015 by Daedalus Enterprises.

Entities:  

Keywords:  aerosol therapy; dry powder inhalers; inhaled medications; metered-dose inhalers; nebulizers; patient adherence; patient education

Mesh:

Substances:

Year:  2015        PMID: 26070585     DOI: 10.4187/respcare.03854

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  6 in total

Review 1.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

2.  Factors affecting satisfaction with education program for chronic airway disease in primary care settings.

Authors:  Andrew Kim; Yong Il Hwang; Joo Hee Kim; Seung Hun Jang; Sunghoon Park; Ji Young Park; Ki-Suck Jung; Kwang Ha Yoo; Yong Bum Park; Hyoung Kyu Yoon; Chin Kook Rhee; Deog Kyeom Kim; Ho-Kee Yum
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  The use of nebulized pharmacotherapies during the COVID-19 pandemic.

Authors:  Sanjay Sethi; Igor Z Barjaktarevic; Donald P Tashkin
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

4.  Preclinical Development of Orally Inhaled Drugs (OIDs)-Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?

Authors:  Dania Movia; Adriele Prina-Mello
Journal:  Animals (Basel)       Date:  2020-07-24       Impact factor: 2.752

5.  Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD).

Authors:  Magdalena Humenberger; Andreas Horner; Anna Labek; Bernhard Kaiser; Rupert Frechinger; Constanze Brock; Petra Lichtenberger; Bernd Lamprecht
Journal:  BMC Pulm Med       Date:  2018-10-19       Impact factor: 3.317

Review 6.  Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD.

Authors:  James F Donohue; Donald A Mahler; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.